AI-Powered News AnalysisCompare coverage across the political spectrum
Back to Dashboard
Amgen owes $20.2 million in antibody patent lawsuit, US jury says - Reuters

Amgen owes $20.2 million in antibody patent lawsuit, US jury says - Reuters

Amgen owes $20.2 million in antibody patent lawsuit, US jury says Reuters

June 12, 2026 at 09:00 PM Original source
4 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
4 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

All Coverage

Amgen owes $20.2 million in antibody patent lawsuit, US jury says - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOVk54b1g2SXZ6cFo2ejVzMlJ6N0tabXJFV1E4MXpfYVc0QjYtNGh6Q204WEZ5Wi0wTmkyVHc5SENJZG5XSkZUUks2eFJmbE44MEcyT0tfaHJWYU5fdk1tMUhPNGRrTWJFUnJiN0QwVWJMc1ZEeFZMSi03STVtaGJKMEt2RTFDSmJYZWY3blVzR0hTM3hpVF94UTFRTXZrRXNuV016d05GZTA2eGot?oc=5" target="_blank">Amgen owes $20.2 million in antibody patent lawsuit, US jury says</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Jury Tells Amgen To Pay $20.2M In Antibody Patent Trial
Law360via ai

A Delaware federal jury found that Amgen Inc. and its Teneobio Inc. unit willfully infringed a mouse antibody patent held by Harbour Antibodies BV, awarding $20.2 million in damages—the full amount sought by Harbour.

80%
Amgen owes $20.2 million in antibody patent lawsuit, US jury says
MarketScreenervia ai

A U.S. jury has determined that Amgen Inc. is liable for $20.2 million in damages for willfully infringing a mouse antibody patent asserted by Harbour Antibodies BV and others.

80%
Amgen owes $20.2 million in antibody patent lawsuit, US jury says
TradingView Newsvia ai

A U.S. jury has found Amgen Inc. liable for $20.2 million in damages for willfully infringing a mouse antibody patent held by Harbour Antibodies BV and others.

80%